
Wellness firm XpresSpa Group and the Metropolitan Washington Airports Authority (MWAA) have announced the opening of two XpresCheck Covid-19 testing centres at Dulles International Airport (IAD) and Reagan National Airport (DCA) in the US.

Navigate your business through the ‘new normal’
- COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments
- Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards
- Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical
MarketPlace Development, the contractor supervising the concessions programme at both airports, will administer the agreement.
MWAA president and CEO John Potter said: “We have seen growing interest from airport customers in having Covid testing in airports as more countries require visitors to have a negative Covid test prior to travelling.”
The pop-up facility at Dulles International Airport is situated pre-security in the main terminal on the baggage claim level.
This testing centre has nine separate rooms and can conduct more than 500 tests a day.
Reagan National Airport also has a pop-up testing facility in the current XpresSpa location before security in National Hall near Terminal B.
With four separate testing rooms, this facility can conduct more than 300 tests a day.
XpresSpa CEO Doug Satzman said: “We are pleased to have opened these two XpresCheck facilities in Washington, DC. Our focus remains to provide reliable and convenient testing for all airline employees and passengers to ensure they feel safe and confident when travelling through our nation’s capital.”
Both the testing centres provide rapid molecular Covid-19 and polymerase chain reaction (PCR) tests.
The rapid Covid-19 test provides instant results, whereas the PCR test results are given within three days.
Although health insurance is not accepted on-site, the documentation will allow testing claims to be sent directly by the customer to health insurance firms.
Both tests are available by appointment or on a walk-in basis.

Navigate your business through the ‘new normal’
- COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments
- Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards
- Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical